LMR Partners’s Rockwell Medical RMTI Stock Holding History

LMR Partners’s Portfolio RMTI Stock Details RMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-341	Closed	-$34K	–	1164
2021 Q2	$34K	Buy	+341	New	+$35.2K	﹤0.01%	1032

Other funds holding RMTI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

VCA

Verdence Capital Advisors Hunt Valley, Maryland $1.72B AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

SkyOak Wealth Southfield, Michigan $546M AUM 18.14% 1-Year Est. Return

LMR Partners's RMTI Position: Q3 2021 in Review

LMR Partners sold out of Rockwell Medical (RMTI) in Q3 2021, closing a stake of 341 shares — an estimated $34K sold.

LMR Partners first reported a position in RMTI in Q2 2021 and held it in 1 quarter. The position peaked at $34K in Q2 2021. 62 funds tracked by Wall St. Rank hold RMTI as of Q3 2021.

LMR Partners reported no remaining Rockwell Medical position as of Q3 2021 after selling out during the quarter.
LMR Partners sold 341 Rockwell Medical shares in Q3 2021, an estimated $34K.
LMR Partners first reported a position in Rockwell Medical in Q2 2021 and held it in 1 quarter.
LMR Partners's Rockwell Medical position peaked at $34K in Q2 2021.
62 funds tracked by Wall St. Rank held Rockwell Medical as of Q3 2021.

Based on LMR Partners's 13F filing for Q3 2021, filed 15 Nov 2021.